XML 17 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 324 $ 377
Restricted cash 52 22
Financial investments, at fair value 202 235
Receivables, net 356 356
Default funds and margin deposits 4,219 3,988
Other current assets 304 235
Assets held for sale 0 297
Total current assets 5,457 5,510
Property and equipment, net 371 400
Goodwill 6,369 6,586
Intangible assets, net 2,328 2,468
Other non-current assets 330 390
Total assets 14,855 15,354
Current liabilities:    
Accounts payable and accrued expenses 176 177
Section 31 fees payable to SEC 21 128
Accrued personnel costs 145 170
Deferred revenue 257 161
Other current liabilities 173 85
Default funds and margin deposits 4,219 3,988
Short-term debt 808 480
Liabilities held for sale 0 45
Total current liabilities 5,799 5,234
Long-term debt 3,072 3,727
Deferred tax liabilities, net 137 225
Non-current deferred revenue 91 126
Other non-current liabilities 154 162
Total liabilities 9,253 9,474
Commitments and contingencies
Nasdaq stockholders’ equity:    
Common stock, $0.01 par value, 300,000,000 shares authorized, shares issued: 169,423,805 at September 30, 2018 and 172,373,432 at December 31, 2017; shares outstanding: 163,949,047 at September 30, 2018 and 167,441,030 at December 31, 2017 2 2
Additional paid-in capital 2,676 3,024
Common stock in treasury, at cost: 5,474,758 shares at September 30, 2018 and 4,932,402 shares at December 31, 2017 (291) (247)
Accumulated other comprehensive loss (1,184) (862)
Retained earnings 4,399 3,963
Total Nasdaq stockholders’ equity 5,602 5,880
Total liabilities and equity $ 14,855 $ 15,354